Published in Oncogene on May 30, 2011
Stem cell pathways contribute to clinical chemoresistance in ovarian cancer. Clin Cancer Res (2011) 2.03
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. Biochem Pharmacol (2012) 1.65
Hedgehog pathway as a drug target: Smoothened inhibitors in development. Onco Targets Ther (2012) 1.27
Smoothened antagonists reverse taxane resistance in ovarian cancer. Mol Cancer Ther (2012) 1.13
The mesenchymal tumor microenvironment: a drug-resistant niche. Cell Adh Migr (2012) 0.99
Inhibition of CK2α down-regulates Hedgehog/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cells. PLoS One (2012) 0.99
Targeting hedgehog signaling in cancer: research and clinical developments. Onco Targets Ther (2013) 0.99
Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review. Mol Cancer (2015) 0.94
Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction? Oncotarget (2015) 0.91
Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms. Am J Pathol (2011) 0.91
Detection of ABCC1 expression in classical Hodgkin lymphoma is associated with increased risk of treatment failure using standard chemotherapy protocols. J Hematol Oncol (2012) 0.90
The Hedgehog pathway: role in cell differentiation, polarity and proliferation. Arch Toxicol (2015) 0.88
Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines. PLoS One (2016) 0.87
Arsenic trioxide prevents osteosarcoma growth by inhibition of GLI transcription via DNA damage accumulation. PLoS One (2013) 0.87
Aberrant GLI1 Activation in DNA Damage Response, Carcinogenesis and Chemoresistance. Cancers (Basel) (2015) 0.86
CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma. Oncotarget (2015) 0.85
GPCR-like signaling mediated by smoothened contributes to acquired chemoresistance through activating Gli. Mol Cancer (2014) 0.85
Transcriptional regulation of serine/threonine protein kinase (AKT) genes by glioma-associated oncogene homolog 1. J Biol Chem (2013) 0.85
ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivity. Front Pharmacol (2013) 0.84
ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma. Exp Hematol Oncol (2013) 0.84
A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential. Br J Haematol (2012) 0.83
The SHH/Gli pathway is reactivated in reactive glia and drives proliferation in response to neurodegeneration-induced lesions. Glia (2014) 0.82
Evaluation of stem-like side population cells in a recurrent nasopharyngeal carcinoma cell line. Cancer Cell Int (2014) 0.81
JNK signaling maintains the mesenchymal properties of multi-drug resistant human epidermoid carcinoma KB cells through snail and twist1. BMC Cancer (2013) 0.81
Proteasome inhibition reverses hedgehog inhibitor and taxane resistance in ovarian cancer. Oncotarget (2014) 0.81
A genome scale RNAi screen identifies GLI1 as a novel gene regulating vorinostat sensitivity. Cell Death Differ (2016) 0.80
NPPB is a novel candidate biomarker expressed by cancer-associated fibroblasts in epithelial ovarian cancer. Int J Cancer (2014) 0.80
Trimeric G protein-CARMA1 axis links smoothened, the hedgehog receptor transducer, to NF-κB activation in diffuse large B-cell lymphoma. Blood (2013) 0.79
Hedgehog signaling regulates telomerase reverse transcriptase in human cancer cells. PLoS One (2013) 0.79
GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells. Oncotarget (2015) 0.79
Functional inhibition of BCL2 is needed to increase the susceptibility to apoptosis to SMO inhibitors in diffuse large B-cell lymphoma of germinal center subtype. Ann Hematol (2013) 0.78
Inhibition of hedgehog signaling reduces the side population in human malignant mesothelioma cell lines. Cancer Gene Ther (2015) 0.78
Targeting Lung Cancer Stem Cells: Research and Clinical Impacts. Front Oncol (2017) 0.77
Defining causative factors contributing in the activation of hedgehog signaling in diffuse large B-cell lymphoma. Leuk Res (2012) 0.76
Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells. Biomaterials (2015) 0.76
The nuclear import of ribosomal proteins is regulated by mTOR. Oncotarget (2014) 0.76
Efflux transporters in blood-brain interfaces of the developing brain. Front Neurosci (2015) 0.75
Glioma-Associated Oncogene Homolog1 (Gli1)-Aquaporin1 pathway promotes glioma cell metastasis. BMB Rep (2016) 0.75
GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer. Oncotarget (2017) 0.75
Active IKKβ promotes the stability of GLI1 oncogene in diffuse large B-cell lymphoma. Blood (2015) 0.75
YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells. Oncotarget (2016) 0.75
The Hedgehog-GLI pathway in embryonic development and cancer: implications for pulmonary oncology therapy. Oncotarget (2017) 0.75
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma. Oncogene (2017) 0.75
Epigenomic study identifies a novel mesenchyme homeobox2-GLI1 transcription axis involved in cancer drug resistance, overall survival and therapy prognosis in lung cancer patients. Oncotarget (2017) 0.75
ABCG2 and NCF4 polymorphisms are associated with clinical outcomes in diffuse large B-cell lymphoma patients treated with R-CHOP. Oncotarget (2017) 0.75
The role of GLI2-ABCG2 signaling axis for 5Fu resistance in gastric cancer. J Genet Genomics (2017) 0.75
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer (2003) 22.78
MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res (1995) 21.22
Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer (2002) 15.72
Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer (2004) 9.68
The Hedgehog and Wnt signalling pathways in cancer. Nature (2001) 9.19
Mechanisms of cancer drug resistance. Annu Rev Med (2002) 7.91
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med (1993) 6.77
Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol (1999) 6.62
A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A (1998) 6.47
Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity. Nat Med (2010) 4.00
The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer (2007) 3.44
The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem (2004) 3.10
Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res (1999) 2.70
Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat Med (2007) 2.62
A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res (1998) 2.58
Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity. Br J Cancer (2003) 2.33
Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res (2000) 2.32
Role of ABCG2/BCRP in biology and medicine. Annu Rev Pharmacol Toxicol (2006) 2.06
Real-time quantitative PCR. Methods (2001) 2.00
Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. Cancer Res (2001) 1.81
Sonic Hedgehog promotes multiple drug resistance by regulation of drug transport. Oncogene (2007) 1.80
Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1. J Biol Chem (2003) 1.65
Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material. J Pathol (2002) 1.64
Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer. Clin Cancer Res (2004) 1.54
Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response. Clin Cancer Res (2006) 1.52
Gli2 is targeted for ubiquitination and degradation by beta-TrCP ubiquitin ligase. J Biol Chem (2006) 1.51
Complete characterization of the human ABC gene family. J Bioenerg Biomembr (2001) 1.46
Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias. Clin Cancer Res (2004) 1.41
Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene. Biochim Biophys Acta (2001) 1.40
ABCG2 -- a transporter for all seasons. FEBS Lett (2004) 1.38
How I treat patients with diffuse large B-cell lymphoma. Blood (2007) 1.36
ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases. Int J Cancer (2004) 1.35
Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization. Int J Cancer (2002) 1.29
Aberrant promoter methylation of the ABCG2 gene in renal carcinoma. Mol Cell Biol (2006) 1.26
The ABCG2 resistance network of glioblastoma. Cell Cycle (2009) 1.24
Low levels of ABCG2 expression in adult AML blast samples. Blood (2002) 1.23
Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation. Leukemia (2010) 1.22
Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-cell lymphoma. Mod Pathol (2009) 1.22
Overlapping and distinct transcriptional regulator properties of the GLI1 and GLI2 oncogenes. Genomics (2006) 1.21
BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemia. Leukemia (2002) 1.17
Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells. Mol Cancer Ther (2009) 1.16
Expression and functional analyses of breast cancer resistance protein in lung cancer. Clin Cancer Res (2003) 1.15
Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target. Mol Cancer Res (2008) 1.14
Multidrug resistance in lymphomas. J Clin Oncol (1994) 1.13
ABCG2 expression is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma. Oncology (2007) 1.12
The bone marrow stromal environment is a major factor in myeloma cell resistance to dexamethasone. Exp Hematol (1998) 1.11
Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma. Cancer Res (2009) 1.11
Sonic hedgehog is produced by follicular dendritic cells and protects germinal center B cells from apoptosis. J Immunol (2005) 1.10
Non-consensus GLI binding sites in Hedgehog target gene regulation. BMC Mol Biol (2010) 1.07
Hedgehog signaling maintains chemoresistance in myeloid leukemic cells. Oncogene (2010) 1.04
Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells. Oncogene (2010) 1.02
Hedgehog signal transduction: from flies to vertebrates. Exp Cell Res (1999) 1.00
The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane. Biochem Biophys Res Commun (2000) 0.98
BCRP mRNA expression v. clinical outcome in 40 adult AML patients. Leuk Res (2005) 0.96
Expression of the BCRP gene (ABCG2/MXR/ABCP) in childhood acute lymphoblastic leukaemia. Br J Haematol (2002) 0.93
Constitutive activation of the shh-ptc1 pathway by a patched1 mutation identified in BCC. Oncogene (2005) 0.93
Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis. Leukemia (2008) 0.91
BCRP gene polymorphisms are associated with susceptibility and survival of diffuse large B-cell lymphoma. Carcinogenesis (2007) 0.91
Immunohistochemical expression of multidrug resistance proteins as a predictor of poor response to chemotherapy and prognosis in patients with nodal diffuse large B-cell lymphoma. Oncology (2005) 0.88
Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein. Leukemia (2004) 0.87
Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma. Blood (2006) 0.87
Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients. Leuk Res (2010) 0.87
Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study. Ann Hematol (2004) 0.87
Expression of P-glycoprotein and anionic glutathione S-transferase genes in non-Hodgkin's lymphoma. Leuk Res (1993) 0.86
The increased expression of receptor activator of nuclear-kappaB ligand (RANKL) of multiple myeloma bone marrow stromal cells is inhibited by the bisphosphonate ibandronate. J Cell Biochem (2010) 0.77
Response of the ABCG2 promoter in T47D cells and BeWo cells to sex hormone treatment. Mol Biol Rep (2008) 0.77
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity (2000) 16.03
Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature (1995) 2.56
Isochromosome of the short arm of chromosome 12: clinically useful markers for male germ cell tumors. J Natl Cancer Inst (1989) 2.19
Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J (1993) 2.18
Cloning of the cDNA encoding an RNA regulatory protein--the human iron-responsive element-binding protein. Proc Natl Acad Sci U S A (1990) 2.03
TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state. Leukemia (2006) 1.79
Mouse IL-17: a cytokine preferentially expressed by alpha beta TCR + CD4-CD8-T cells. J Interferon Cytokine Res (1996) 1.65
Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologies. J Natl Cancer Inst (1991) 1.55
Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment. Ann Oncol (2009) 1.52
Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features. Leukemia (2010) 1.51
Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia. Oncogene (2012) 1.48
Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology (1992) 1.47
Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest (1995) 1.43
Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry (1996) 1.39
[Allergology in the public health service of the Community of Madrid: current situation and opportunities in the XXI century public health system]. An Sist Sanit Navar (2015) 1.37
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial. Leukemia (2013) 1.26
Immature human dendritic cells express asialoglycoprotein receptor isoforms for efficient receptor-mediated endocytosis. J Immunol (2001) 1.24
Human Kaposi's sarcoma cell-mediated tumorigenesis in human immunodeficiency type 1 tat-expressing transgenic mice. J Natl Cancer Inst (2000) 1.23
Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation. Leukemia (2010) 1.22
Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. Am J Trop Med Hyg (1995) 1.18
Hypersensitivity to latex, chestnut, and banana. Ann Allergy (1993) 1.16
miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells. Cell Death Dis (2013) 1.09
Definition and spatial location of mouse interleukin-2 residues that interact with its heterotrimeric receptor. EMBO J (1993) 1.04
Migratory anisocoria--a novel clinical entity. Am Rev Respir Dis (1986) 1.03
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma. Ann Oncol (2009) 1.01
Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies. Leukemia (2008) 0.99
Cytogenetic findings in mantle cell lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities. Am J Clin Pathol (2001) 0.98
Phylogenetic evidence for the transfer of Pseudomonas cocovenenans (van Damme et al. 1960) to the genus Burkholderia as Burkholderia cocovenenans (van Damme et al. 1960) comb. nov. Int J Syst Bacteriol (1995) 0.98
Reappraisal of the effect of Ca2+ on the activity of liver microsomal glucose-6-phosphatase. J Biol Chem (1990) 0.98
An iron-sulfur cluster plays a novel regulatory role in the iron-responsive element binding protein. Biometals (1992) 0.98
Oncogene amplification in human gliomas: a molecular cytogenetic analysis. Oncogene (1994) 0.97
Leukemic differentiation of a mediastinal germ cell tumor. Genes Chromosomes Cancer (1989) 0.96
Autocatalytic activation of human legumain at aspartic acid residues. FEBS Lett (1998) 0.94
Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors. J Natl Cancer Inst (1990) 0.93
A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome. Ann Oncol (2011) 0.92
Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension (1997) 0.92
The epidermal growth factor receptor in glioblastoma: genomic amplification, protein expression, and patient survival data in a therapeutic trial. Clin Neuropathol (1995) 0.92
Survey of blindness and visual impairment in Bioko, Equatorial Guinea. Br J Ophthalmol (2002) 0.91
Suppressor of cytokine signaling 3 expression in anaplastic large cell lymphoma. Leukemia (2004) 0.90
Inhibition of the calcium- and voltage-dependent big conductance potassium channel ameliorates cisplatin-induced apoptosis in spiral ligament fibrocytes of the cochlea. Neuroscience (2005) 0.90
Purine and pyrimidine metabolism in human gliomas: relation to chromosomal aberrations. Br J Cancer (1994) 0.89
The therapeutic potential of p53 reactivation by nutlin-3a in ALK+ anaplastic large cell lymphoma with wild-type or mutated p53. Leukemia (2009) 0.89
[Autoimmunity and paraneoplastic neurologic syndromes]. Rev Neurol (Paris) (1991) 0.89
Detection of preferential NRAS mutations in human male germ cell tumors by the polymerase chain reaction. Genes Chromosomes Cancer (1990) 0.89
[Prevalence of fascioliasis in humans, horses, pigs, and wild rabbits in 3 Chilean provinces]. Bol Oficina Sanit Panam (1993) 0.89
ACTH and beta-endorphin in transcendental meditation. Physiol Behav (1998) 0.88
[Echinococcosis/hydatidosis in the VII Region of Chile: diagnosis and educational intervention]. Rev Panam Salud Publica (2000) 0.87
Acute hemichorea due to infarction in the corona radiata. J Neurol (1989) 0.86
CD5+ B lymphocytes in HIV infection: relationship to immunological progression of disease. Clin Immunol Immunopathol (1993) 0.85
Induction of TLR4-dependent CD8+ T cell immunity by murine β-defensin2 fusion protein vaccines. Vaccine (2011) 0.84
Paraneoplastic cerebellar degeneration with anti-Yo antibody in a man. Neurology (1995) 0.84
Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients. Bone Marrow Transplant (2012) 0.84
Multiple infusions of anti-epidermal growth factor receptor (EGFR) monoclonal antibody (EMD 55,900) in patients with recurrent malignant gliomas. Eur J Cancer (1996) 0.83
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma. Ann Oncol (2007) 0.83
Isochromosome 12p in non-seminoma cell lines: karyologic amplification of c-ki-ras2 without point-mutational activation. Oncogene (1990) 0.82
Leptin, reproduction and sex steroids. Pituitary (2002) 0.82
Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21). Leukemia (2011) 0.82
[Fascioliasis in populations of rural areas with high prevalence of animal infection]. Rev Med Chil (1992) 0.81
Treatment of complete and partial obstruction of the nasolacrimal system with polyurethane stents: initial experience. Cardiovasc Intervent Radiol (1998) 0.81
CD4+ cells in human ejaculates. Hum Reprod (1995) 0.81
[Chronic exposure to environmental lead in Chilean infants]. Rev Med Chil (1997) 0.81
Self-reported menopausal symptoms in a racially diverse population and soy food consumption. Maturitas (2013) 0.81
[Occurrence of depression symptoms and their influence factors in perimenopausal women]. Zhonghua Fu Chan Ke Za Zhi (1996) 0.80
Kinetics of a nucleotide pyrophosphatase in the plasma membrane of the fat cell. Biochim Biophys Acta (1980) 0.80
Synthesis of highly potent second-generation taxoids through effective kinetic resolution coupling of racemic beta-lactams with baccatins. Chirality (2000) 0.80
Distinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum. Neuroscience (2008) 0.80
Basic fibroblast growth factor inhibits osteogenic differentiation of stem cells from human exfoliated deciduous teeth through ERK signaling. Oral Dis (2011) 0.79
Effect of polar side chains at position 172 on thermal stability of 3-isopropylmalate dehydrogenase from Thermus thermophilus. FEBS Lett (1997) 0.79
[Prevalence of premenstrual syndrome in reproductive women and its influential factors]. Zhonghua Fu Chan Ke Za Zhi (1998) 0.79
Analysis of the NF2 tumor-suppressor gene and of chromosome 22 deletions in gliomas. Int J Cancer (1995) 0.78
Vasoactive intestinal peptide stimulates long-chain fatty acid oxidation and inhibits acetyl-coenzyme A carboxylase activity in isolated rat enterocytes. J Biol Chem (1989) 0.78
Primary amyloidosis presenting as renal infarction. Eur Radiol (1996) 0.78
Different serum cytokine levels in chronic vs. acute Anisakis simplex sensitization-associated urticaria. Parasite Immunol (2011) 0.77
CD40L activation of dendritic cells down-regulates DORA, a novel member of the immunoglobulin superfamily. Mol Immunol (1998) 0.77
A cytogenetic study of 19 recurrent gliomas. Cancer Genet Cytogenet (1994) 0.77
EPOCH-F: a novel salvage regimen for multiple myeloma before reduced-intensity allogeneic hematopoietic SCT. Bone Marrow Transplant (2010) 0.77
Effect of acute sublethal endotoxaemia on in vitro digital vascular reactivity in horses. J Vet Med A Physiol Pathol Clin Med (2005) 0.77
Mononuclear cell subpopulations in human follicular fluid from stimulated cycles. Am J Reprod Immunol (1990) 0.77
Prevalence of p53 overexpression or mutations, but not k-ras mutations, in recurrent patients affected by colorectal-carcinoma. Int J Oncol (1995) 0.76
[Spontaneous tumor regression in a patient with multiple myeloma. Report of another case]. Rev Med Univ Navarra (1998) 0.76
Metabolic and drug distribution studies do not support direct inhibitory effects of metformin on intestinal glucose absorption. Diabete Metab (1995) 0.76
Marginal-zone B-cell lymphoma of extranodal mucosa-associated lymphoid tissue type: molecular genetics provides new insights into pathogenesis. Adv Anat Pathol (2001) 0.76
Long-lasting transcriptional refractoriness triggered by a single exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine. Neuroscience (2012) 0.76
Anaphylactic shock due to fosfomycin. Allergy (1998) 0.76
Thoracic aorta units: an opened avenue to cardiologists. Int J Cardiol (2005) 0.75
Nasal Hyperreactivity: Nonspecific Nasal Provocation Tests. Review by the Rhinoconjunctivitis Committee of the Spanish Society of Allergy and Clinical Immunology. J Investig Allergol Clin Immunol (2015) 0.75
Increase of large granular lymphocytes in human ejaculate containing antisperm antibodies. Hum Reprod (1998) 0.75
[Anaerobic infection without injuries, in a patient with cyanogenous cardiopathy]. Gac Med Mex (1977) 0.75
[Erythrocyte delta-aminolevulinic dehydratase and protoporphyrin in lead exposure]. Rev Med Chil (1982) 0.75
[Acute renal insufficiency secondary to discontinuous treatment with rifampicin]. Rev Clin Esp (1981) 0.75
[Candidiasis in Santo Tomás Hospital]. Rev Med Panama (1985) 0.75
[Antagonism of barbituric coma by stimulating products. Experimental study]. Rev Esp Anestesiol Reanim (1978) 0.75
Analysis of chromosome 12 abnormalities in male germ cell cancers. Recent Results Cancer Res (1991) 0.75
The electrocardiogram of the Capibara (Hydrochoerus hydrochaeris, Linné). Zentralbl Veterinarmed A (1978) 0.75